Tissuegraft
TissueGraft is a company dedicated to developing innovative biological materials with high biocompatibility and bioactivity for research and regenerative medicine applications. It collaborates with international scientific communities and industry partners to create advanced solutions for tissue engineering, surgical applications, and regenerative therapies.
Industries
Nr. of Employees
small (1-50)
Products
Decellularized matrices (research products)
Acellular matrices derived from animal tissues intended for research use and scaffold development.
Functionalized matrices (customized)
Biological matrices chemically activated and enriched with bioactive molecules to direct tissue regeneration and reduce infection risk.
Hernia containment patch (decellularized pericardium)
Patch derived from decellularized bovine pericardium, available as plain or chemically activated/functionalized, designed to integrate with abdominal wall tissues and support regeneration.
Biological vascular substitutes
Small‑section vascular substitutes produced from decellularized porcine vessels, intended for peripheral vascular access or short vascular repairs; designed for haemocompatibility and integration.
Research scaffolds: powders, hydrogels, electrospun materials
A portfolio of research-grade scaffolding formats including powders, hydrogels and electrospun materials for soft tissue regenerative medicine research.
Decellularized organ matrices for ex vivo models (kidney, liver)
Decellularized small‑animal kidney and liver matrices developed to provide organ‑mimicking substrates for ex vivo models of renal and hepatic pathologies.
Decellularized matrices (research products)
Acellular matrices derived from animal tissues intended for research use and scaffold development.
Functionalized matrices (customized)
Biological matrices chemically activated and enriched with bioactive molecules to direct tissue regeneration and reduce infection risk.
Hernia containment patch (decellularized pericardium)
Patch derived from decellularized bovine pericardium, available as plain or chemically activated/functionalized, designed to integrate with abdominal wall tissues and support regeneration.
Biological vascular substitutes
Small‑section vascular substitutes produced from decellularized porcine vessels, intended for peripheral vascular access or short vascular repairs; designed for haemocompatibility and integration.
Research scaffolds: powders, hydrogels, electrospun materials
A portfolio of research-grade scaffolding formats including powders, hydrogels and electrospun materials for soft tissue regenerative medicine research.
Decellularized organ matrices for ex vivo models (kidney, liver)
Decellularized small‑animal kidney and liver matrices developed to provide organ‑mimicking substrates for ex vivo models of renal and hepatic pathologies.
Services
Production of acellular matrices from animal tissues and organs for research and implantable scaffold development.
Chemical activation and surface functionalization to stably attach bioactive agents (antibiotics, growth factors, anticoagulants, peptides) to matrices to modulate post‑implant responses.
Biocompatibility, cytocompatibility, hemocompatibility (TEG), and mechanical property testing of biomaterials and matrices.
Collaborative R&D, prototyping, method development and scientific consultancy for biomaterials and regenerative‑medicine projects.
Production of acellular matrices from animal tissues and organs for research and implantable scaffold development.
Chemical activation and surface functionalization to stably attach bioactive agents (antibiotics, growth factors, anticoagulants, peptides) to matrices to modulate post‑implant responses.
Biocompatibility, cytocompatibility, hemocompatibility (TEG), and mechanical property testing of biomaterials and matrices.
Collaborative R&D, prototyping, method development and scientific consultancy for biomaterials and regenerative‑medicine projects.
Expertise Areas
- Tissue decellularization
- Matrix functionalization and bioactive enrichment
- Vascular tissue engineering
- Soft tissue repair and implantable scaffolds
Key Technologies
- Tissue decellularization
- Matrix functionalization (stable binding of bioactives)
- Plasma surface treatment
- Electrospinning
News & Updates
Sfida Vincente @ GRP Televisione – 28/02/2019
A televised challenge featuring TissueGraft.
BioMET 2018 – Vellore, India
Presentation of TissueGraft's innovations at BioMET 2018.
Soft Tissue Repair Global Market – Forecast To 2023
Market analysis report mentioning TissueGraft's sector.
Novara come il Quebec sa far crescere le start up
Article highlighting TissueGraft's growth in Novara.
Premio America Innovazione
TissueGraft received the America Innovation Award.
Market forecast indicating the significance of tissue repair sector.
Sfida Vincente @ GRP Televisione – 28/02/2019
A televised challenge featuring TissueGraft.
BioMET 2018 – Vellore, India
Presentation of TissueGraft's innovations at BioMET 2018.
Soft Tissue Repair Global Market – Forecast To 2023
Market analysis report mentioning TissueGraft's sector.
Novara come il Quebec sa far crescere le start up
Article highlighting TissueGraft's growth in Novara.
Premio America Innovazione
TissueGraft received the America Innovation Award.
Market forecast indicating the significance of tissue repair sector.